<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">177</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-4-86-93</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of integrins αv in the pathogenesis of oral squamous cell carcinoma</article-title><trans-title-group xml:lang="ru"><trans-title>Роль интегринов αv в патогенезе плоскоклеточного рака полости рта</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7713-1891</contrib-id><name-alternatives><name xml:lang="en"><surname>Tuguzbaeva</surname><given-names>G. M.</given-names></name><name xml:lang="ru"><surname>Тугузбаева</surname><given-names>Г. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>3 Lenina St., Ufa 450008, Republic Bashkortostan</p></bio><bio xml:lang="ru"><p>Гульнара Маратовна Тугузбаева.</p><p>Республика Башкортостан, 450008 Уфа, ул. Ленина, 3</p></bio><email>gulnaritta@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlov</surname><given-names>V. N.</given-names></name><name xml:lang="ru"><surname>Павлов</surname><given-names>В. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>3 Lenina St., Ufa 450008, Republic Bashkortostan</p></bio><bio xml:lang="ru"><p>Республика Башкортостан, 450008 Уфа, ул. Ленина, 3</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Bashkir State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>86</fpage><lpage>93</lpage><history><date date-type="received" iso-8601-date="2019-01-03"><day>03</day><month>01</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-01-03"><day>03</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Tuguzbaeva G.M., Pavlov V.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Тугузбаева Г.М., Павлов В.Н.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Tuguzbaeva G.M., Pavlov V.N.</copyright-holder><copyright-holder xml:lang="ru">Тугузбаева Г.М., Павлов В.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/177">https://umo.abvpress.ru/jour/article/view/177</self-uri><abstract xml:lang="en"><p>The initiation of carcinoma progression is attributed to significant disorders in the synthesis of macromolecules that affect physiological processes in the epithelial cells of oral mucosa. It is known that the integrin family receptors are crucial for regenerative and reparative functions of the normal epithelium. In addition to their well-established physiological role, some types of integrins are the major determinants of malignant transformations. In particular, the results of recent studies in molecular oncology reveal the importance of αv integrins in the pathogenesis of carcinomas, including oral squamous cell carcinoma. This review aims to analyse the significance of αv integrins in the key processes of malignant growth and metastasis of oral squamous cell carcinoma. The prospects of using αv integrins as prognostic molecular markers and targets for developing novel diagnostic and therapeutic methods in the management of oral cancer are discussed.</p></abstract><trans-abstract xml:lang="ru"><p>Инициация злокачественного роста карцином связана со значительными нарушениями синтеза макромолекул, контролирующих процессы жизнедеятельности эпителиальных клеток. Известно, что семейство интегриновых рецепторов играет важную роль в обеспечении регенеративных и репаративных свойств эпителия. Помимо реализации физиологических функций некоторые типы интегринов обладают доказанным онкогенным потенциалом. В частности, результаты недавних исследований в области молекулярной онкологии показывают значимость интегриновых рецепторов типа αv в патогенезе карцином, в том числе рака полости рта. В настоящем обзоре проанализированы механизмы участия интегринов αv в ключевых процессах злокачественного роста и метастазирования плоскоклеточного рака полости рта. Продемонстрирована перспективность использования интегринов αv в качестве прогностических молекулярных маркеров и мишеней для разработки новых методов диагностики и лечения злокачественных новообразований челюстно-лицевой области.</p></trans-abstract><kwd-group xml:lang="en"><kwd>oral squamous cell carcinoma</kwd><kwd>integrin αv</kwd><kwd>metastasis</kwd><kwd>cancer invasion</kwd><kwd>cancer migration</kwd><kwd>anoikis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>плоскоклеточный рак полости рта</kwd><kwd>интегрины αv</kwd><kwd>метастазирование</kwd><kwd>опухолевая инвазия</kwd><kwd>опухолевая миграция</kwd><kwd>аноикис</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9(4):274-84. DOI: 10.1038/nrc2622. PMID: 19308067.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Xing Y., Zhang J., Lin H. et al. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer 2016;122(4):534—45. DOI: 10.1002/cncr.29780. PMID: 26554754.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10(1):9—22. DOI: 10.1038/nrc2748. PMID: 20029421.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Harburger D.S., Calderwood D.A. Integ-rin signalling at a glance. J Cell Sci 2009;122(Pt 2):159—63. DOI: 10.1242/jcs.018093. PMID: 19118207.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shinohara M., Nakamura S., Sasaki M. et al. Expression of integrins in squamous cell carcinoma of the oral cavity. Correlations with tumor invasion and metastasis. Am J Clin Pathol 1999;111(1):75—88. PMID: 9894457.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wang D., Muller S., Amin A.R. et al. The pivotal role of integrin p1 in metastasis of head and neck squamous cell carcinoma. Clin Cancer Res 2012;18(17):4589—99. DOI: 10.1158/1078-0432.CCR-11-3127. PMID: 22829201.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Amaral Pereira A.L., Lopes F.F., da Cruz M.C. et al. Role of integrins in the carcinogenesis of squamous cell carcinoma of the tongue and lower lip. Appl Immu-nohistochem Mol Morphol 2013;21(2):154—8. DOI: 10.1097/PAI.0b013e31825905e5. PMID: 22595951.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jones J., Watt F.M., Speight P.M. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med 1997;26(2):63—8. PMID: 9049904.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Wang W., Otsetov A.G., Wang E. et al. Integrin p6 — a potential marker for the early malignant transformation in prostate cancer. J Urol Nephrol Open Access 2016;2(1):1—7. DOI: 10.15226/2473-6430/2/1/00113.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Xuan S.H., Zhou Y.G., Pan J.Q. et al. Overexpression of integrin av in the human nasopharyngeal carcinoma associated with metastasis and progression. Cancer Biomark 2013;13(5):323—8. DOI: 10.3233/CBM-130361. PMID: 24440971.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Wu YJ., Pagel M.A., Muldoon L.L. et al. High av integrin level of cancer cells is associated with development of brain metastasis in athymic rats. Anticancer Res 2017;37(8):4029-40. DOI: 10.21873/anti-canres.11788. PMID: 28739685.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J Cell Sci 2006;119(19):3901—3. DOI: 10.1242/jcs.03098. PMID: 16988024.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Thomas G.J., Poomsawat S., Lewis M.P. et al. avp6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 2001;116(6):898—904. DOI: 10.1046/j.1523-1747.2001.01352.x. PMID: 11407978.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Thomas G.J., Nystrom M.L., Marshall J.F. avp6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 2006;35(1):1 —10. DOI: 10.1111/j.1600-0714.2005.00374.x. PMID: 16393247.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315(26):1650—9. DOI: 10.1056/NEJM198612253152606. PMID: 3537791.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Duperret E.K., Dahal A., Ridky T.W. Focal-adhesion-independent integrin-av regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion. J Cell Sci 2015;128(21):3997—4013. DOI: 10.1242/jcs.175539. PMID: 26359297.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Savar A., Acin S., Gonzalez C.L. et al. Loss of epithelial p53 and av integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment. Oncogene 2015;34(4):516—24. DOI: 10.1038/onc.2013.585. PMID: 24469034.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jones J., Sugiyama M., Speight P.M. et al. Restoration of avp5 integrin expression in neoplastic keratinocytes results in increased capacity for terminal differentiation and suppression of anchorage-independent growth. Oncogene 1996;12(1):119—26. PMID: 8552382.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Breuss J.M., Gallo J., DeLisser H.M. et al. Expression of the p6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995;108 (Pt 6):2241-51. PMID: 7673344.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Jones J., Sugiyama M., Watt F.M. et al. Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. J Pathol 1993;169(2):235—43. DOI: 10.1002/path.1711690210. PMID: 8445489.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Nystrom M.L., McCulloch D., Weinreb P.H. et al. Cyclooxygenase-2 inhibition suppresses avp6 integrin-dependent oral squamous carcinoma invasion. Cancer Res 2006;66(22):10833—42. DOI: 10.1158/0008-5472.CAN-06-1640. PMID: 17108119.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hamidi S., Salo T., Kainulainen T. et al. Expression of avp6 integrin in oral leukoplakia. Br J Cancer 2000;82(8):1433-40. DOI: 10.1054/bjoc.1999.1130. PMID: 10780523.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Xue H., Atakilit A., Zhu W. et al. Role of the avp6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 2001;288(3):610—8. DOI: 10.1006/bbrc.2001.5813. PMID: 11676487.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Hayashido Y., Kitano H., Sakaue T. et al. Overexpression of integrin av facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin avp8 with type I collagen. Int J Oncol 2014;45(5):1875—82. DOI: 10.3892/ijo.2014.2642. PMID: 25190218.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Janes S.M., Watt F.M. New roles of integrins in squamous-cell carcinoma. Nat Rev Cancer 2006;6(3):175-83. DOI: 10.1038/nrc1817. PMID: 16498442.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Koivisto L., Grenman R., Heino J. et al. Integrins a5p1, avp1, and avp6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Exp Cell Res 2000;255(1):10—7. DOI: 10.1006/excr.1999.4769. PMID: 10666329.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Ramos Gde O., Bernardi L., Lauxen I. et al. Fibronectin modulates cell adhesion and signaling to promote single cell migration of highly invasive oral squamous cell carcinoma. PLoS One 2016;11(3):e0151338. DOI: 10.1371/jour-nal.pone.0151338. PMID: 26978651.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Thomas G.J., Lewis M.P., Whawell S.A. et al. Expression of the avp6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 2001;117(1):67—73. DOI: 10.1046/j.0022-202x.2001.01379.x. PMID: 11442751.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Gopal S., Veracini L., Grall D. et al. Fi-bronectin-guided migration of carcinoma collectives. Nat Commun 2017;8:14105. DOI: 10.1038/ncomms14105. PMID: 28102238.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Thomas G.J., Lewis M.P., Hart I.R. et al. avp6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 2001;92(5):641—50. PMID: 11340566.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ramos D.M., But M., Regezi J. et al. Expression of integrin p6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol 2002;21(3):297—307. PMID: 12009335.</mixed-citation></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Li H.X., Zheng J.H., Fan H.X. et al. ExE	pression of avp6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J Oral Pathol Med 2013;42(7):547—56. DOI: 10.1111/jop.12044. PMID: 23331428.</mixed-citation><mixed-citation xml:lang="ru">Li H.X., Zheng J.H., Fan H.X. et al. ExE pression of avp6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J Oral Pathol Med 2013;42(7):547—56. DOI: 10.1111/jop.12044. PMID: 23331428.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><mixed-citation>Ylipalosaari M., Thomas G.J., Nystrom M. et al. avp6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells. Exp Cell Res 2005;309(2):273—83. DOI: 10.1016/j.yex-cr.2005.06.008. PMID: 16024014.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Swan E.A., Jasser S.A., Holsinger F.C. et al. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol 2003;39(7):648—55. PMID: 12907203</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Guadamillas M.C., Cerezo A., Del Pozo MA. Overcoming anoikis-pathways to anchorage-independent growth in cancer. J Cell Sci 2011;124(Pt 19):3189—97. DOI: 10.1242/jcs.072165. PMID: 21940791.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Zhang Y., Lu H., Dazin P. et al. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin av mediate survival signals through focal adhesion kinase. J Biol Chem 2004;279(46):48342—9. DOI: 10.1074/jbc.M407953200. PMID: 15331608.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kamarajan P., Kapila Y.L. An altered fi-bronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Apoptosis 2007;12(12):2221—31. DOI: 10.1007/s10495-007-0138-9. PMID: 17879163.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Janes S.M., Watt F.M. Switch from avp5 to avp6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol 2004;166(3):419—31. DOI: 10.1083/jcb.200312074. PMID: 15289499.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Seguin L., Desgrosellier J.S., Weis S.M. et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol 2015;25(4): 234-40. DOI: 10.1016/j.tcb.2014.12.006. PMID: 25572304.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Nakamura T., Shinriki S., Jono H. et al. Osteopontin-integrin avp3 axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma. FEBS Lett 2015;589(2):231 —9. DOI: 10.1016/j.febs-let.2014.12.004. PMID: 25497015.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Stojanovic N., Brozovic A., Majhen D. et al. Integrin avp3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418). Biochim Biophys Acta 2016;1863(8):1969—78. DOI: 10.1016/j.bbamcr.2016.04.019. PMID: 27108184.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Hehlgans S., Eke I., Cordes N. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling. Int J Radiat Oncol Biol Phys 2012;83(5):e669—76. DOI: 10.1016/j.ijrobp.2012.01.065. PMID: 22483702.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Sansing H.A., Sarkeshik A., Yates J.R. et al. Integrin ap1, avp, a6p effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance. Biochem Biophys Res Commun 2011;406(2):171—6. DOI: 10.1016/j.bbrc.2011.01.109. PMID: 21291860.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Damiano J.S. Integrins as novel drug targets for overcoming innate drug resistance. Curr Cancer Drug Targets 2002;2(1): 37—43. PMID: 12188919.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Nemeth J.A., Nakada M.T., Trikha M. et al. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest 2007;25(7):632—46.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Li Y., Drabsch Y., Pujuguet P. et al. Genetic depletion and pharmacological targeting of av integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res 2015;17:28. DOI: 10.1186/s13058-015-0537-8. PMID: 25849225.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>van der Horst G., van den Hoogen C., Buijs J.T. et al. Targeting of av-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia 2011;13(6):516—25. DOI: 10.1593/neo.11122. PMID: 21677875</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>van der Horst G., Bos L., van der Mark M. et al. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma. PLoS One 2014;9(9):e108464. DOI: 10.1371/journal.pone.0108464. PMID: 25247809.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Keereweer S., Mol I.M., Kerrebijn J.D. et al. Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer. J Surg Oncol 2012 Jun;105(7):714—8. DOI: 10.1002/jso.22102. PMID: 21952950.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Bunschoten A., Buckle T., Visser N.L. et al. Multimodal interventional molecular imaging of tumor margins and distant me-tastases by targeting avp3 integrin. Chem-biochem 2012;13(7):1039—45. DOI: 10.1002/cbic.201200034. PMID: 22505018.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Huang H., Bai Y.L., Yang K. et al. Optical imaging of head and neck squamous cell carcinoma in vivo using arginine-glycine-aspartic acid peptide conjugated near-infrared quantum dots. Onco Targets Ther 2013;6:1779—87. DOI: 10.2147/OTT.S53901. PMID: 24324343.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Li H., Huang D., Gao Z. et al. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and avp6 integrin. Int J Oncol 2013;42(5):1674—81. DOI: 10.3892/ijo.2013.1873. PMID: 23546449.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Hatley R.J.D., Macdonald S.J.F., Slack R.J. et al. An av-RGD integrin inhibitor toolbox: drug discovery insight, challenges and opportunities. Angew Chem Int Ed Engl 2018;57(13):3298—321. DOI: 10.1002/anie.201707948. PMID: 28944552.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Nothelfer E.M., Zitzmann-Kolbe S., Gar-cia-Boy R. et al. Identification and characterization of a peptide with affinity to head and neck cancer. J Nucl Med 2009;50(3):426—34. DOI: 10.2967/jnumed.108.058123. PMID: 19223422.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Hsiao J.R., Chang Y., Chen Y.L. et al. Cyclic avp6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma. Head Neck 2010;32(2):160—72. DOI: 10.1002/hed.21166. PMID: 19572290.</mixed-citation></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Samsonov R.B., Radzhabova Z.A., Cheburkin Yu.V et al. Epigenetic regulation of gene expression in head and neck squamous cell carcinoma: therapeutic perspectives. Opukholi go-lovy i shei = Head and Neck Tumors 2016;6(4):35—44 (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Самсонов Р.Б., Раджабова З.А., Чебур-кин Ю.В. и др. Эпигенетические механизм^! регуляции генной экспрессии в развитии плоскоклеточного рака головы и шеи: терапевтические перспективы. Опухоли головы и шеи 2016;6(4):35—44. DOI: 10.17650/2222-1468-2016-6-4-35-44.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><mixed-citation>Cai Q.Q., Dong Y.W., Wang R. et al. MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin aV expression. Sci Rep 2017;7:40733. DOI: 10.1038/srep40733. PMID: 28094803.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Yu S., Li L., Tian W. et al. PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial mesenchymal transition. Br J Pharmacol 2018;175(11):3111—30. DOI: 10.1111/bph.14352. PMID: 29722931.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Beer A.J., Grosu A.L., Carlsen J. et al. [18F]galacto-RGD positron emission tomography for imaging of avp3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007;13(22 Pt 1): 6610—6. DOI: 10.1158/1078-0432.CCR-07-0528. PMID: 18006761.</mixed-citation></ref></ref-list></back></article>
